Cornell announces Fleming research fellow: Researcher will study roots of Legionnaires' disease
Postdoctoral researchers at Cornell's Ithaca campus who have received a Ph.D. or M.D. within two years of the application deadline are eligible for the fellowship and must be nominated by their lab's principal investigator. The fellowship provides a stipend and research funding to train in research areas aligned with the Weill Institute's focus on answering fundamental questions in cell biology.
Hoch will use his fellowship to study the bacterium Legionella pneumophila, which causes 90 percent of cases of infectious Legionnaires' disease and may lead to flulike symptoms and pneumonia. L. pneumophila commonly lives inside freshwater amoeba and can get into people's lungs through water aerosols from air conditioners. In humans, the bacterium injects proteins into cells with a tiny molecular syringe, and then enters the cell in a capsule and takes control of cellular functions to enhance its own virulence and ability to infect other cells.
Hoch aims to determine the role of a specific, but little-known protein, believed to be an enzyme that protects the bacterium by modifying proteins in the host cell that would otherwise destroy it. In the last year, Hoch has already begun determining the 3-D structure of the bacterial protein, said Weill Institute Director Scott Emr.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.